312 related articles for article (PubMed ID: 11653221)
1. If a subject incurs obligations and carries them out, then consent is a contract: Dahl v. HEM Pharmaceuticals (Part II).
Maloney DM
Hum Res Rep; 1996 Jan; 11(1):4-5. PubMed ID: 11653221
[No Abstract] [Full Text] [Related]
2. Despite "clinical hold," subjects have right to keep getting experimental drug: Dahl v. HEM Pharmaceuticals Corporation (Part III).
Maloney DM
Hum Res Rep; 1996 Feb; 11(2):4-5. PubMed ID: 11654437
[No Abstract] [Full Text] [Related]
3. Informed consent is binding contract: Dahl v. HEM Pharmaceuticals.
Maloney DM
Hum Res Rep; 1995 Dec; 10(12):4-5. PubMed ID: 11653220
[No Abstract] [Full Text] [Related]
4. Walking a thin line: distinguishing between research and medical practice during Operation Desert Storm.
Schuchardt EJ
Columbia J Law Soc Probl; 1992; 26(1):77-115. PubMed ID: 11651647
[No Abstract] [Full Text] [Related]
5. Considering experimentation and elusive truth: informed consent made difficult.
Brodeur D
Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
[No Abstract] [Full Text] [Related]
6. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
Kobasic DM
J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
[No Abstract] [Full Text] [Related]
7. Informed consent process is deemed "legally and ethically invalid" by witness.
Maloney DM
Hum Res Rep; 1995 Jan; 10(1):4-5. PubMed ID: 11660008
[No Abstract] [Full Text] [Related]
8. Court tells jury to ignore human subject protection regulations.
Maloney DM
Hum Res Rep; 1995 Mar; 10(3):4-5. PubMed ID: 11654195
[No Abstract] [Full Text] [Related]
9. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
10. IRB review of adverse events in investigational drug studies.
Prentice ED; Gordon B
IRB; 1997; 19(6):1-4. PubMed ID: 11656910
[No Abstract] [Full Text] [Related]
11. FDA's new rule on treatment use and sale of investigational new drugs.
Levine RJ
IRB; 1987; 9(4):1-4. PubMed ID: 11649946
[No Abstract] [Full Text] [Related]
12. Informed consent process and document is criticized in court.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
[No Abstract] [Full Text] [Related]
13. Can a court order participation in research?
Holder AR
IRB; 1987; 9(4):8-9. PubMed ID: 11649949
[No Abstract] [Full Text] [Related]
14. Regulation of drug treatments for HIV and AIDS: a contractarian model of access.
Salbu SR
Yale J Regul; 1994; 11(2):401-53. PubMed ID: 11660141
[No Abstract] [Full Text] [Related]
15. Proposal on waiver of informed consent poses major issues for research ethics.
Maloney DM
Hum Res Rep; 1997 Sep; 12(9):1-3. PubMed ID: 11660533
[No Abstract] [Full Text] [Related]
16. A military exception to "informed consent": Doe v. Sullivan.
Moran PJ
St Johns Law Rev; 1993; 66(3):847-63. PubMed ID: 11652729
[No Abstract] [Full Text] [Related]
17. Federal agency's final rule says informed consent forms must be dated.
Maloney DM
Hum Res Rep; 1996 Dec; 11(12):1-2. PubMed ID: 11655034
[No Abstract] [Full Text] [Related]
18. Legal and ethical concepts involved in informed consent to human research.
Woody KJ
Calif West Law Rev; 1981; 18(1):50-79. PubMed ID: 11658328
[No Abstract] [Full Text] [Related]
19. A drug company report: what is the same and what is changing with respect to inclusion/exclusion of women in clinical trials.
Goldmann BJ
Food Drug Law J; 1993; 48(2):169-74. PubMed ID: 11653139
[No Abstract] [Full Text] [Related]
20. FDA revises informed consent regulations for emergency research.
Menasché A; Levine RJ
IRB; 1995; 17(5-6):19-22. PubMed ID: 11653359
[No Abstract] [Full Text] [Related]
[Next] [New Search]
